GlassScriptPhysician profile
Richa K Patel
NPI 1457776577
$2,129.21
in general payments reported to CMS, 2019-2025
17 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,074 · 2020: $18.77 · 2021: $31.90 · 2022: $137 · 2023: $367 · 2024: $376 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $868.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $746.64 | 2019 | |
| Novo Nordisk INC | $249.67 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Medtronic, INC. | $232.19 | 2023-2024 | Minimed 780g |
| Astrazeneca Pharmaceuticals LP | $202.52 | 2019-2023 | Breztri, Farxiga |
| Radius Health, INC. | $135.22 | 2019 | |
| Beta Bionics, INC. | $122.58 | 2024 | Ilet Bionic Pancreas |
| Amgen INC. | $112.71 | 2019-2022 | |
| Lilly USA, LLC | $54.07 | 2022-2023 | Jardiance, Zepbound |
| Ucb, INC. | $53.66 | 2023 | Cimzia |
| Abbvie INC. | $51.98 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.68 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $40.10 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $20.00 | 2024 | Gardasil, Gardasil 9, Capvaxive |
| Insulet Corporation | $16.66 | 2023 | Omnipod |
| Si-Bone, INC. | $16.12 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $15.97 | 2023 | Krystexxa |
| Abbott Laboratories | $14.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richa Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.